請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70231完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 謝吉隆(Ji-Lung Hsieh) | |
| dc.contributor.author | Chieh Chen | en |
| dc.contributor.author | 陳潔 | zh_TW |
| dc.date.accessioned | 2021-06-17T04:24:33Z | - |
| dc.date.available | 2019-08-18 | |
| dc.date.copyright | 2018-08-18 | |
| dc.date.issued | 2018 | |
| dc.date.submitted | 2018-08-15 | |
| dc.identifier.citation | 王美卿(2010)。探討台南地區父母親對於青少女施打子宮頸癌疫苗之意願。成功大學護理學系學位論文。
王棣鴻(2009)。社群網站使用與滿足之研究-以台灣 Facebook 使用者為例。銘傳大學傳播管理所碩士論文。 李金治、李思賢、陳天順、盧玉玫、林勳(2010)。金門縣婦女對接種人類乳突病毒疫苗之意向及相關因素研究。健康促進暨衛生教育雜誌。30:1-16。 李佩珍、蕭惠文(2004)。從使用與滿足理論看競標網站。2004中華傳播學刊年會。台北。 李樹人(2008年12月24日)。全球27國推動公費子宮頸癌疫苗 金門做到了。聯合晚報。取自http://olddoc.tmu.edu.tw/pinging/comment/co069.htm 周芊、康力平(2014)。網路社會動員的新研究取徑:社群巨量資料分析。空大人文學報。23:29-46。 林欣柔(2009)。強制施打?免費施打?從公共衛生倫理評析人類乳突病毒HPV疫苗之法律與政策爭議。法學新論。第11期。頁153-180。 林惟崧(2017年10月8日)。連廠商都無法保證 政府憑什麼幫HPV疫苗背書有效20年。上報。取自 http://www.upmedia.mg/news_info.php?SerialNo=26039 林敬旺、蔡文正、曾盈甄(2011)。父母對於青少女接種人類乳突病毒疫苗接受度與影響因素探討。澄清醫護管理雜誌,7(2):38-50。 姚克武、洪兆嘉、蔣亞萍、葉國樑(2011)。探討新竹市護理人員推荐民眾接種人類乳突病毒疫苗意願的相關因素。健康促進暨衛生教育雜誌,31:71-90。 柳姚仁(2015)。運用Facebook公開資料監測類流感疫情。淡江大學資訊管理學系碩士在職專班學位論文。 翁秀琪(1997)。大眾傳播理論與實證。台北:三民書局。 財團法人資訊工業策進會(2017年5月1日)。八成以上台灣人愛用Facebook、Line坐穩社群網站龍頭 1人平均擁4個社群帳號 年輕人更愛YouTube和IG。財團法人資訊工業策進會新聞。取自 https://www.iii.org.tw/Press/NewsDtl.aspx?nsp_sqno=1934&fm_sqno=14 馬耀祖(2013)。博士生回應(一):從眼球到社群—新興媒體的轉化與契機。傳播研究與實踐。3(1):77-83。 張卿卿、羅文輝(2009)。政論性談話節目影響之探討。新聞學研究。98(2):47-91。 張嘉馨(2008)。藥物副作用資訊之溝通效果。東華企業管理學系學位論文。 陳拱北預防醫學基金會(2007)。公共衛生學(上冊)。巨流圖書公司。 陳奕安、江子揚、蔡銘峰、薛化元、劉吉軒(2016)。 適用於中文史料文本之標記式主題模型分析方法研究。「第七屆數位典藏與數位人文國際研討會論文集」。台北:臺灣大學。 黃筱珮、楊惠君(2016年6月6日)。HPV疫苗解碼/新疫苗登台!「嘉喜9」更強、更貴,副作用也可能更大?。民報。取自http://www.peoplenews.tw/news/a9814a0e-88bd-4b02-b3e1-cec68a6b2edf 黃筱珮(2016年6月9日)。HPV疫苗解碼/適應症外使用普遍 產後婦女被鎖定推銷。民報。取自http://www.peoplenews.tw/news/e84bde14-5ffc-45d2-ad47-48ea3b74767c 溫麗芬、洪麗珍、張彩秀(2008)。青少女自費接種子宮頸癌疫苗意向之相關因素探討。台灣公共衛生雜誌,27(2):133-142。 楊心怡、李佳欣(2016年12月6日)。子宮頸癌疫苗知多少/全面開打,家長最焦慮的「不良報告」。康健雜誌。取自http://www.commonhealth.com.tw/article/article.action?nid=73709 詹明錦、邱勝康、吳建昌、方啟泰(2013)。人類乳突病毒疫苗接種政策:公共衛生倫理觀點。台灣公共衛生雜誌,32(4):309-319。 潘豐泉、黃俊英、蘇惠甘(2012)。家長特質對自費子宮頸癌疫苗接種之行為意圖影響效果。寶建醫護與管理雜誌,10(2):1-13。 蔣宜婷(2018年5月10日)。台灣首宗訴訟案揭黑布:HPV疫苗全面公費接種的陰影。報導者。取自https://www.twreporter.org/a/hpv-vaccine-adverse-effects 蔡美瑛(1995)。議題設定理論之發展:從領域遷徙、理論延展到理論整合。新聞學研究,50(2):97-124。 賴雅淳(2017年2月24日)。醫療好康報 少女福音!8縣市免費提供子宮頸癌疫苗,民眾足足省萬元。鏡週刊。取自https://www.mirrormedia.mg/story/20170217fin004/ 鄭文芳(2011)。人類乳突病毒疫苗在女性預防接種成效介紹。愛之關懷。74 : 22-27。 鄭宇君、陳百齡(2014)。探索2012年台灣總統大選之社交媒體浮現社群:鉅量資料分析取徑。新聞學研究。120(4):121-165。 劉榮(2007年11月28日)。台北都會 子宮頸癌疫苗免費打 衛局挨轟。自由時報。取自http://news.ltn.com.tw/news/local/paper/171320 衛生福利部國民健康署84年癌症登記年報。(2009年11月30日)。取自https://www.hpa.gov.tw/Pages/TopicList.aspx?nodeid=269&idx=0 衛生福利部國民健康署92年癌症登記年報。(2009年11月30日)。取自https://www.hpa.gov.tw/Pages/TopicList.aspx?nodeid=269&idx=1 衛生福利部國民健康署-HPV疫苗(無日期)。取自衛生福利部國民健康署網頁 https://www.hpa.gov.tw/Pages/List.aspx?nodeid=212 聯合晚報(2007年12月19日)。默沙東 捐勵馨子宮頸癌疫苗。取自 http://www.tw16.net/monographData.asp?m1No=14&m2No=130&m3No=557&mM o=8546 謝懿安(2016年12月1日)。子宮頸癌疫苗知多少/什麼是HPV疫苗?該怎麼選?。康健雜誌。取自http://www.commonhealth.com.tw/article/article.action?nid=73638 全国子宮頸がんワクチン被害者連絡会(2015)。子宮頸がんワクチン接種後の症状[紀錄片]。全国子宮頸がんワクチン被害者連絡会。取自https://www.youtube.com/watch?v=BGjn1ZOnRiY American Cancer Society. (2018). Can Cervical Cancer Be Prevented? Web site:https://www.cancer.org/cancer/cervical-cancer/prevention-and-early-detection/can-cervical-cancer-be-prevented.html Bednarczyk, R. A., Davis, R., Ault, K., Orenstein, W., & Omer, S. B. (2012). Sexual activity–related outcomes after human papillomavirus vaccination of 11-to 12-year-olds. Pediatrics, 130(5), 798-805. Blei, D. M., Ng, A. Y., & Jordan, M. I. (2003). Latent dirichlet allocation. Journal of machine Learning research, 3, 993-1022. Blei, D. M. (2012). Probabilistic topic models. Communications of the ACM, 55(4), 77-84. Briones, R., Nan, X., Madden, K., & Waks, L. (2012). When vaccines go viral: an analysis of HPV vaccine coverage on YouTube. Health communication, 27(5),478-485. Carpenter, L. M., & Casper, M. J. (2009). A tale of two technologies: HPV vaccination, male circumcision, and sexual health. Gender & Society, 23(6), 790-816. Casciotti, D. M., Smith, K. C., & Klassen, A. C. (2014). Topics associated with conflict in print news coverage of the HPV vaccine during 2005 to 2009. Human vaccines & immunotherapeutics, 10(12), 3466-3474. Centers for Disease Control and Prevention. (2015). Introduction to HPV. Web site: https://www.cdc.gov/cancer/knowledge/provider-education/hpv/introduction.htm Centers for Disease Control and Prevention. (2016). HPV Vaccine Recommadations. Web site: https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html Centers for Disease Control and Prevention. (2017). HPV Vaccine Information For Young Women. Web site: https://www.cdc.gov/std/hpv/stdfact-hpv-vaccine-young-women.htm Centers for Disease Control and Prevention. (2018). Clinical Immunization Safety Assessment (CISA) Project. Web site: https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/cisa/index.html Centers for Disease Control and Prevention. (2018). Emergency Preparedness for Vaccine Safety. Web site: https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/emergencypreparedness/index.html Centers for Disease Control and Prevention. (2018). Vaccine Safety Datalink (VSD). Web site:https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vsd/index.html Cooper Robbins, S. C., Bernard, D., McCaffery, K., Brotherton, J. M., & Skinner, S. R. (2010). “I just signed”: Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psychology, 29(6), 618. Gostin, L. O., & Wiley, L. F. (2016). Public health law: power, duty, restraint. Univ of California Press. Habel, M. A., Liddon, N., & Stryker, J. E. (2009). The HPV Vaccine: A Content Analysis of Online News Stories. Journal of Women’s Health, 18, 401–407. Harper, D. M., & DeMars, L. R. (2017). HPV vaccines–a review of the first decade. Gynecologic oncology, 146(1), 196-204. Ho, G. Y., Bierman, R., & Beardsley, L. (1998). chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338(7), 423-428. Keelan, J., Pavri, V., Balakrishnan, R., & Wilson, K. (2010). An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs. Vaccine, 28(6), 1535-1540. Kim, K. S., Park, S., Ko, K. N., Yi, S., & Cho, Y. J. (2014). Current status of human papillomavirus vaccines. Clinical and experimental vaccine research, 3(2), 168-175. Keim-Malpass, J., Mitchell, E. M., DeGuzman, P. B., Stoler, M. H., & Kennedy, C. (2017). Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy. Risk management and healthcare policy, 10, 29-32. Liddon, N.C., Leichliter, J.S., Markowitz, L.E. (2012). Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am. J. Prev. Med. 42, 44–52. Love, B., Himelboim, I., Holton, A., & Stewart, K. (2013). Twitter as a source of vaccination information: content drivers and what they are saying. American Journal of Infection Control, 41(6), 568-570. Madden, K., Nan, X., Briones, R., & Waks, L. (2012). Sorting through search results: a content analysis of HPV vaccine information online. Vaccine, 30(25), 3741-3746. Maier, D., Waldherr, A., Miltner, P., Wiedemann, G., Niekler, A., Keinert, A., Pfetsch, B., Heyer, G., Reber, U., Häussler, T., Schmid, P, H., & Adam, S. (2018). Applying LDA topic modeling in communication research: Toward a valid and reliable methodology. Communication Methods and Measures, 12(2-3), 93-118. Massey, P. M., Leader, A., Yom-Tov, E., Budenz, A., Fisher, K., & Klassen, A. C. (2016). Applying multiple data collection tools to quantify human papillomavirus vaccine communication on Twitter. Journal of medical Internet research, 18(12). McRee, A. L., Reiter, P. L., & Brewer, N. T. (2012). Parents’ Internet use for information about HPV vaccine. Vaccine, 30(25), 3757-3762. McCombs, M. E., & Shaw, D. L. (1972). The agenda-setting function of mass media. Public opinion quarterly, 36(2), 176-187. McCombs, M., & Evatt, D. (1995). Issues and attributes: Exploring a new dimension in agenda setting. Communicacion y Sociedad, 8(1), 7-32. Nan, X., & Madden, K. (2012). HPV vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions. Health communication, 27(8), 829-836. National Institutes of Health. (2013). Cervical Cancer. Web site: https://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=76 Penţa, M. A., & Băban, A. (2014). Dangerous agent or saviour? HPV vaccine representations on online discussion forums in Romania. International journal of behavioral medicine, 21(1), 20-28. Remes, P., Selestine, V., Changalucha, J., Ross, D. A., Wight, D., de Sanjosé, S., Kapiga, S., Hayes, R, J., & Watson-Jones, D. (2012). A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine, 30(36), 5363-5367. Rondy, M., Van Lier, A., Van de Kassteele, J., Rust, L., & De Melker, H. (2010). Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine, 28(9), 2070-2075. Signe, D., & Michael, B. (2015). The Vaccinated Girls: Sick and Betrayed [Documentary]. Denmark. Suzuki, S., & Hosono, A. (2018). No Association between HPV Vaccine and Reported Post-Vaccination Symptoms in Japanese Young Women: Results of the Nagoya Study. Papillomavirus Research, 5, 96-103. U.K. Association of HPV Vaccine Injured Daughters. (2015). UK Family Speak: HPV Vaccines Changed Our Lives [Documentary]. The United Kingdom. U.S. Food & Drug Administration. (2009). Gardasil Vaccine Safety. Web site: https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm179549.html Vadaparampil, S. T., Kahn, J. A., Salmon, D., Lee, J. H., Quinn, G. P., Roetzheim, R., Bruder, K., Malo, T.L., Proveaux, T., Zhao, X., Halsey, N., & Giuliano, A. R. (2011). Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634-8641. Vaccine Adverse Event Reporting System. (2018). About VAERS. Web site: https://vaers.hhs.gov/about.html Warner, E. L., Ding, Q., Pappas, L., Bodson, J., Fowler, B., Mooney, R., Kirchhoff, A.C., & Kepka, D. (2017). Health Care Providers’ Knowledge of HPV Vaccination, Barriers, and Strategies in a State with Low HPV Vaccine Receipt: Mixed-Methods Study. JMIR cancer, 3(2), e12. World Health Organization. (2018). Cervical cancer prevention and control saves lives in the Republic of Korea. Web site: http://www.who.int/features/2018/cervical-cancer-republic-of-korea/en/ World Health Organization. (2016). Guide to introducing HPV vaccine into national immunization programmes. Web site: http://www.who.int/immunization/documents/ISBN_9789241549769/en/ World Health Organization. (2015). GACVS Statement on Safety of HPV vaccines. Web site: http://www.who.int/vaccine_safety/committee GACVS_HPV_statement_17Dec2015.pdf?ua=1 Zimet, G. D., Rosberger, Z., Fisher, W. A., Perez, S., & Stupiansky, N. W. (2013). Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Preventive medicine, 57(5), 414-418. Zhang, C., Gotsis, M., & Jordan-Marsh, M. (2013). Social media microblogs as an HPV vaccination forum. Human vaccines & immunotherapeutics, 9(11), 2483-2489. Zhang, N., Tsark, J., Campo, S., & Teti, M. (2015). Facebook for health promotion: female college students' perspectives on sharing HPV vaccine information through facebook. Hawai'i Journal of Medicine & Public Health, 74(4), 136. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70231 | - |
| dc.description.abstract | 2006 年人類乳突病毒(HPV)疫苗問世,至今超過 80 個國家納入國家疫苗接 種計畫(NIP)、約 30 個國家採取公費接種。臺灣則在 2006 年末核准 HPV 疫苗 上市,由各地方政府自行編列預算推動施打,直到今年 11 月將納為國家政策,統 一補助國中青少女接種。施打 HPV 疫苗的安全性、有效性、副作用與政策制定的 爭議等在國外的新聞、社群網站上已被大眾廣泛討論,並引發許多研究在探討閱 聽眾對此些議題的態度認知。相較之下,儘管 HPV 疫苗在國內已推動十一年,可 能因為由各地方政府補助施打,沒有全臺統一政策,且施打至今未有明顯爭議事 件產生的緣故,雖有相關研究卻未引起重視和討論。
在 2018 年 11 月即將全國性統一補助國中青少女接種前,本研究希望透過蒐 集國內主流媒體及線上社群的相關言論,借鏡國外的相關研究,觀察、分析、來 了解 HPV 疫苗跨媒體的傳散情形、及其引起的輿論意見,讓政府得以在政策施行 前,對輿論部分做更多的解釋與資訊揭露,媒體則能在旁發揮監督與傳播功能。 為了瞭解這個問題,首先探討國外的新聞、社群訊息如何在國內線上社群上被再 製並傳遞?再來國內在主流媒體與線上社群如何討論 HPV 疫苗?討論主題有哪些? 以不同平台如傳統主流媒體、線上社群作為媒介,被傳遞的訊息類型、討論方式 又如何反映出媒介的特性?最後則是在社群訊息中,哪些議題事件有較多的討論? 討論的立場又是什麼? 本研究將以自動化文字探勘輔助文本分析方法進行分析,如抽取國外傳遞到 國內的案例、採用主題探勘模型找出 HPV 疫苗的討論主題、比較不同主題的平台 差異,以及哪些主題觸動較多討論。再進一步透過人工文本分析的方式了解這些 討論背後可能的脈絡與動機。 研究結果發現,國外傳遞到國內的事件有研討會與期刊發表、政策執行以及副作用案例。其中副作用例子成為臺灣媒體後續報導上的借鏡素材,也是立法院凍結全面接種預算的原因之一。在國內的 18 個主題分類中,社群平台與主流媒體 在主題上有顯著差異。進一步分析篇數較多的九個主題,其中主題一「預防觀念、 問答集」彙整社群訊息討論問題,包含「該不該打疫苗?去哪打?打幾價?」; 跨平台資訊傳遞如主題三「雲林縣疫苗施打」有同篇報導在社群平台發佈後,當 天或隔天再轉傳到主流媒體報導的情形;也有如主題十六「抹片加疫苗雙重防癌」, 雖然主流媒體與社群平台皆有類似資訊,但都沒有重複。 最後觀察輿論發現,討論集中在主題一「預防觀念、問答集」,分成藝人在社群分享並邀請閱聽人按讚轉貼、個人的接種經驗分享討論,以及是否該接種的討論中,年輕女性與產後婦女都擔心接種後的效果,前者是因發生過性行為,後者則因醫院推薦接種。另外,全面接種的資訊在討論中引起明顯的反彈,原因為疫苗的副作用,以及公費接種有圖利廠商嫌疑。 | zh_TW |
| dc.description.abstract | Ever since its introduction in 2006, the Human Papillomavirus (HPV) vaccine has been included in the National Vaccination Program (NIP) in more than 80 countries and is publicly funded among 30 countries. In Taiwan, HPV vaccine was officially approved in late 2006 but has been budgeted and promoted by individual municipalities only. Recently, the government has decided to roll out a new policy in November 2018 to make it a nationally-funded vaccine for all female students in Grade 7.
The discussions and controversies regarding the vaccine's safety, effectiveness, and side effects have been widely debated on public media and called for research upon public attitudes toward relevant policies in many countries. However, there has been little attention to the public responses toward the upcoming national vaccine program in Taiwan despite the presence and local promotion of the HPV vaccine within the past 11 years. This research uncovers and examines the dissemination of HPV vaccine-relevant information across major media and online communities through collecting and analyzing news articles and corresponding comments. The overarching objective is to assist the government, the media, and other involved actors in understanding public attitudes, identifying potential concerns, and responding accordingly to emerging discussions through policy communication or adjustment in a timely and effective manner. The research first discusses how foreign news and social media information are reproduced and transmitted in domestic coverage and online discussions. Second, the research investigates how the HPV vaccine is discussed in mainstream paper media and online communities in Taiwan and identifies important topics of such discussions. Next, it dives into the characteristics among different media platforms (i.e., traditional paper media and social platforms). These differences are revealed in the types of information that are spread across and the ways the audience discuss the various topics. Finally, popular events and topics that trigger more discussions, as well as the stances in them, are highlighted and analyzed. This study adopts text-mining and content analysis methods. For example, it extracts important international HPV vaccine side-effect cases that appear in domestic discussions and uses topic models to induce major topics. Finally, qualitative context analysis is conducted to sort out the contexts and motivations beneath the debates. The study found that the types of foreign information that enters domestic media platforms include academic publications, policy implementations, and side-effect cases. For example, reported cases of side effects not only became key issues followed up by domestic media coverage but also contributed to the budget freeze of the national HPV vaccination program. Furthermore, among the 18 identified topics, there are noticeable differences in what and how they are being discussed between social platforms and the mainstream paper media. The topic surrounding the vaccination program in Yunlin County, for example, showed the cross-platform information transmission of the same coverage from social platforms to paper media with a time lag of 1 to 2 days. There are also examples, such as the topic regarding the combination of Pap test and HPV vaccine, that yield similar but non-repetitive information. Among all disscussions, the “FAQ” topic, which covers the eligibility, benefits, and procedures of the vaccination, is the most popular one. It can be further divided into three categories: information shared by celebrities, personal experiences, and discussions of whether to vaccinate or not. Teenage girls and postpartum women are especially worried about the efficacy of the vaccine due to preceding sexual behavior and hospital recommendations respectively. Finally, the opposing and questioning opinions toward the national HPV vaccination program in the discussion are mainly derived from the unresolved side effects and unclear secret profits potentially benefitting the pharmaceutical companies. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-17T04:24:33Z (GMT). No. of bitstreams: 1 ntu-107-R05342012-1.pdf: 1923437 bytes, checksum: ca018f308dffa7b9245e2d58c1543d0e (MD5) Previous issue date: 2018 | en |
| dc.description.tableofcontents | 謝辭................................................................................................................................ii
中文摘要...................................................................................................................... iii Abstract .......................................................................................................................... v 圖目錄...........................................................................................................................ix 表目錄............................................................................................................................ x 第一章 緒論..................................................................................................................1 1.1 導言..................................................................................................................1 1.2 研究背景..........................................................................................................2 1.2.1 名詞解釋...............................................................................................3 1.2.2 疫苗使用情形.......................................................................................5 1.2.3 疫苗政策...............................................................................................7 1.3 研究問題與目的............................................................................................12 1.4 研究貢獻........................................................................................................14 第二章 文獻探討........................................................................................................15 2.1 HPV 疫苗的討論議題 ..................................................................................15 2.2 社群網站作為討論 HPV 疫苗之平台 .........................................................16 2.2.1 主流媒體與社群平台差異................................................................. 16 2.2.2 國外社群與 HPV 疫苗研究 .............................................................. 19 2.3 國內 HPV 疫苗之研究 .................................................................................23 2.3.1 國內 HPV 疫苗研究分類 ..................................................................24 2.3.2 國內社群網站與 HPV 疫苗研究缺乏 ..............................................29 2.4 小結................................................................................................................30 第三章 研究方法........................................................................................................31 3.1 資料說明........................................................................................................31 3.2 資料分析方法................................................................................................38 第四章 研究結果........................................................................................................42 4.1 國外的新聞在臺灣傳遞情形........................................................................42 4.2 國內 HPV 疫苗主題的平台差異 .................................................................47 4.3 梳理 HPV 疫苗議題輿論意見 .....................................................................62 第五章 結論................................................................................................................75 5.1 研究結論........................................................................................................75 5.2 研究建議........................................................................................................80 參考文獻...................................................................................................................... 81 | |
| dc.language.iso | zh-TW | |
| dc.subject | 社群輿論分析 | zh_TW |
| dc.subject | HPV 疫苗 | zh_TW |
| dc.subject | 子宮頸癌疫苗 | zh_TW |
| dc.subject | 全面接種 | zh_TW |
| dc.subject | 主題模型 | zh_TW |
| dc.subject | Public Opinion Mining | en |
| dc.subject | HPV Vaccine | en |
| dc.subject | Cervical Cancer | en |
| dc.subject | Comprehensive Vaccination | en |
| dc.subject | Topic Model | en |
| dc.title | 跨國、跨媒介的健康議題傳散與輿論探討:以 HPV 疫苗為例 | zh_TW |
| dc.title | Health Topics Dissemination and Public Opinions across Nations and Media: A Case Study of HPV Vaccine | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 106-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 劉好迪(Adrian Rauchfleisch) | |
| dc.contributor.oralexamcommittee | 張耀懋(Yao-Mao Chang),林欣柔(Shin-Rou Lin),邱銘心(Ming-hsin Chiu) | |
| dc.subject.keyword | HPV 疫苗,子宮頸癌疫苗,全面接種,主題模型,社群輿論分析, | zh_TW |
| dc.subject.keyword | HPV Vaccine,Cervical Cancer,Comprehensive Vaccination,Topic Model,Public Opinion Mining, | en |
| dc.relation.page | 87 | |
| dc.identifier.doi | 10.6342/NTU201803456 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2018-08-15 | |
| dc.contributor.author-college | 社會科學院 | zh_TW |
| dc.contributor.author-dept | 新聞研究所 | zh_TW |
| 顯示於系所單位: | 新聞研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-107-1.pdf 未授權公開取用 | 1.88 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
